CV/ARL July 2014- 1 -

Abdolaziz Rastegar Lari, Ph.D.Founder and President, Iranian Society of Medical BacteriologyProfessor of Clinical MicrobiologyTehran University of Medical SciencesP.O. Box 14515-717Tehran, IranPhone: +98 21 8670 31 83Fax: +98 21 8670 86 49Email: lari@iums.ac.ir

EDUCATION

1999-2000 Post Doctoral degree in Molecular Epidemiology, University of Tours,Tours, France

1988-1989 Post Doctoral degree in Plasmid Transfer – in vivo/vitro, NationalResearch Institute of Agronomy (I.N.R.A.), Tours, France

1988 Ph.D. in Pharmaceutical Sciences and Clinical Microbiology, Universityof Paris XI, Paris, France

1983-84 M.Sc. in Microbial Ecology, University of Tours, Tour, France1982-83 M.Sc. in Microbiology, University of Montpellier, France1977 B.Sc. in Biology, University of Tabriz, Tabriz, Iran

PROFESSIONAL EXPERIENCE

2009-present Director, Antimicrobial Resistance Research Center, Iran University ofMedical Science, Tehran, Iran

2000-present Consulting Scientist, Exir Pharmaceutical Company, Tehran, Iran1994-1999 Chief, Tohid Burn Center Laboratory, Iran University of Medical Science,

Tehran, Iran1994-1999 Member, Nosocomial Infection control Committee, Tohid Burn Center,

Iran University of Medical Science, Tehran, Iran1998-1999 Consultant of Research, Exir Pharmaceutical Company, Tehran, Iran1992-1998 Consultant of Research, Jaberebne Hayan Pharmaceutical Company,

Tehran, Iran1983-1988 Research Staff of Quantitative Microbiology, Clocheville Children

Hospital, Tours, France1982-1983 Research Staff, Microbiological biochemistry Laboratory, Orleans, France1981-1982 Research Staff in Immuno-genetic, National Center of Scientific Research

(C.N.R.S.), Orleans, France

CV/ARL July 2014- 2 -

ACADEMIC APPOINTMENT

2005-2007 Professor and Chair, Department of Microbiology, Iran University ofMedical Sciences, Tehran, Iran

2003-present Professor of Microbiology, Iran University of Medical Sciences, Tehran,Iran

1999-2002 Associated Professor of Microbiology, Iran University of MedicalSciences, Tehran, Iran

1999-2000 Visiting Professor of Microbiology, University of Tours, Tours, France1993-99 Assistant Professor of Microbiology, Iran University of Medical Sciences,

Tehran, Iran1989-1992 Assistant Professor of Microbiology, Shiraz University of Medical

Sciences, Shiraz, Fars, Iran1988-1989 Assistant Professor of Microbiology, University Institute of Technology,

Tours, France1986-1987 Resident in Microbiology, National Institute of Agronomical Research

(I.N.R.A), Tours, France1987-1988 Resident in Microbiology, National Institute of Agronomical Research

(I.N.R.A), Versailles, France

REVIEW BORD & REFREE

Founder and Director of journal of Medical Bacteriology 2012-present Director, Antimicrobial Resistance Research Center. 2010-2014 Editor in Chief, Iranian Journal of Medical Microbiology, 2007-2009 Member, Editorial Board, Scientific Journal of Medical Microbiology and Kurdistan

University of Medical Sciences, 2000-present Peer-review journals referee: Journal of Antimicrobial Chemotherapy, Burns, Saudi

Medical Journal, Archive of Iranian Medicine, Journal of Medicinal Plants, Foodborneand Pathogens and Disease, African Journal of Microbiology Research, BMCMicrobiology Editorial Team, World Journal of Agricultural Sciences (WJAS), MedicalJournal of the Islamic Republic of Iran, ZUMS Journal, etc.

PROFESSIONAL ASSOCIATION MEMBERSHIP

Member, French Society for Microbiology (Société Française de Microbiologie),1988-present

Member, European Society of Clinical Microbiology and Infectious Diseases(ESCMID), 1989-present

CV/ARL July 2014- 3 -

Member of Iranian Pharmaceutical Society, 1989-present Member, Medical Council of Islamic Republic of Iran, 1989-present Member, Executive Committe, Iranian Society for Microbiology, 2001-2004 President, Executive Committe, Iranian Society for Microbiology, 2004-2006 President, Executive Committe, Iranian Society for Bacteriology, 2009-present

Authors h index = 13

PUBLICATIONS

1) Parviz Owlia, Rahim Nosrati, Reza Alaghehbandan, Abdolaziz Rastegar Lari.

Antimicrobial susceptibility differences among Mucoid and non-Mucoid Pseudomonas

aeruginosa isolates. GMS Hygiene and Infection Control. GMS Hygiene and Infection

Control 2014, Vol. 9(2),1-6

2) N. RABIRAD, M. MOHAMMADPOOR, A. RASTEGAR LARI, A. SHOJAIE,R. BAYAT, M. ALEBOuYEH. Antimicrobial susceptibility patterns of the gram-negative bacteria isolated from septicemia in Children’s Medical Center, Tehran, Iran. Jprev med hyg. J prev med hyg 2013; 54: 1-207

3) Maryam Beheshti, Malihe Talebi, Abdollah Ardebili, Abbas Bahador, Abdolaziz

Rastegar Lari. Detection of AdeABC efflux pump genes in Tetracycline-resistant

Acinetobacter baumannii isolates from burn and Ventilator- associated pneumonia

patients. Journal of Pharmacy and Bioallied Sciences. In press.

4) Ardebili A., Talebi M., Azimi L. Rastegar Lari A. effect of efflux pump inhibitorcarbonyl cyanide 3-chlorophenylhydrazone on the minimum inhibitory concentration ofciprofloxacin in Acineftobacter baumannii clinical isolates. Jundishapur J Microbiol.2014; 7(1): e8691

5) Rastegar Lari A., Azimi L.,Rahbar M., Alaghebandan R., Sattarzadeh-tabrizi M. Firstreport of Klebsiella pneumonia carbapenemaseproducing Pseudomonas aeruginosaisolated from burn patients in Iran: phenotypic and genotypic methods. GMS Hygieneand Infection Control 2014, Vol. 9(1), 1-5

6) Azimi L., Nordmann P., Rastegar Lari A., Bonnin RA. First report of OXA-48-producing Klebsiella pneumoniae strains in Iran. GMS Hygiene and Infection Control2014, Vol. 9(1).

CV/ARL July 2014- 4 -

7) Azimi L., Rastegar Lari A., Talebi M, Ebrahimzadeh Namvar A., Soleymanzadeh-Moghadam S. Evaluation of Phenotypic Methods for Detection of Klebsiella PneumoniaeCarbapenemase-Producing K. Pneumoniae in Tehran.J Med. Bacteriol.2014

8) Soltan Dallal MM, Rastegar Lari A, Sharifi Yazdi MK. Pattern of serotyping andantibiotic resistance of Salmonella in children with diarrhea. Journal of GorganUniversity of Medical Sciences. 2014: 16(1): 100-105

9) Pakzad I., Zayyen M., Taherikalani m., Boustanshenas M., Rastegar Lari A.Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniaeisolated from burn patients. GMS Hygiene and Infection Control 2013, Vol. 8(2),1-6

10) Ebrahimzadeh Namvar A., Afshar M., Asghari B., Rastegar Lari A. Characterisation ofSCCmec elements in methicillin-resistant Staphylococcus aureus isolated from burnpatients. BURNS (2013), http://dx.doi.org/10.1016/j.burns.2013.09.010

11)Rastegar Lari A., Azimi L., Rahbar M, Fallah F., Alaghehbandan R. Phenotypicdetection of Klebsiella pneumoniae carbapenemase among burns patients: First reportfrom Iran. Burns. 2013;39:174-176

12)Mohammad Mehdi Soltan-Dallal, Zohre Kalafi, Abdolaziz Rastegar-Lari, S.KazemHosseini, Abbas Rahimi-Foroushani, Zahra Deilami-Khiabani, Siamak Heidarzadeh . TheEffect of Reduced Bacterial Dilution on Human Amniotic Membrane AntibacterialActivity, in Vitro. Zahedan Journal of Research in Medical Sciences.2013;15(5):6-8.

13)Marzieh Fattahi Dolat Abadi, Sedigheh Mehrabian, Babak Asghari, AmirmortezaEbrahimzadehNamvar, Fatemeh Ezzatifar, Abdolaziz Rastegar Lari. Silvernanoparticles as active ingredient used for alcohol-free mouthwash . GMS Hygiene andInfection Control 2013, Vol. 8(1), ISSN 1863-5245

14)Massoud Hajia, PhD, Fatemeh Fallah, PhD, Goli Angoti, MSc, Abdollah Karimi, MD,Mohamad Rahbar, PhD, Latif Gachkar, MD, Bahram Mokhtari, MD, Anahita Sanaei,MD, Abdolaziz Rastegar Lari, PhD, Comparison of Methods for DiagnosingBrucellosis Lab Medicine Winter 2013 | Volume 44, Number 1 .22-26

15)Amirmorteza Ebrahimzadeh Namvar, Babak Asghari1 Fatemeh Ezzatifar, GholamrezaAzizi, Abdolaziz Rastegar Lari, ; Detection of the intercellular adhesion gene cluster(ica) in clinical Staphylococcus aureus isolates ; GMS Hygiene and Infection Control2013, Vol. 8(1), ISSN 1863-5245

CV/ARL July 2014- 5 -

16)Abdolaziz Rastegar Lari, Reza Alaghehbandan ,. ‘The modified Hodge test foridentification of Klebsiella pneumoniae carbapenemase producing isolates’ respond toletter to the Editor. BURNS . volume 39 . issue 2 . march 2013 : 371-372

17)Mohammad Soltan Dallal, Ailar Sabbaghi, Hedrosha Molla Aghamirzaeie, Abdol Ras-tegar Lari, Mohammad Reza Eshraghian, Jalil Fallah Mehrabad, Zahra RajabiPrevalence of AmpC and SHV β-Lactamases in Clinical Isolates of Escherichia coliFrom Tehran Hospitals : Jundishapur J Microbiol. 2013:6(2) :176-180

18)Raziye Tajalli, Maliheh Nobakht, Hajar Mohammadi-Barzelighi, Shahram Agah,Abdolaziz Rastegar-Lari and Alireza Sadeghipour The Immunohistochemistry andToluidine Blue Roles for Helicobacter pylori Detection in Patients with Gastritis ;Iranian Biomedical Journal 17 (1): 36-41 (January 2013)

19)Ardebili A, Azimi L, Mohammadi-Barzelighi H, Owlia P3, Beheshti M, Talebi M,Jabbari M, Rastegar Lari A : Determination of Resistance Pattern of IsolatedAcinetobacter baumannii from Hospitalized Burned Patients in Motahari Hospital,Tehran zums 2083 :2013

20)Abdolaziz Rastegar Lari, Hajar Mohammadi Barzelighi,Mohammad Arjomandzadegan,Rahim Nosrati, Parviz Owlia. Distribution of Class I Integron among Isolates ofAcinetobacter baumannii Recoverd from Burn Patients. J Med Bacteriol. Vol. 2, No.1, 2(2013): pp. 1-11

21)Azimi L., Rastegar Lari A., Talebi M., Ebrahimzadeh Namvar A., Jabbari M.Comparison between phenotypic and PCR for detection of OXA-23 type and metallo-beta-lactamases producer Acinetobacter spp. GMS Hygiene and Infection Control 2013,Vol. 8(2), 1-6

22)M. Fattahi Dolat abadi, S. Soleymanzadeh, M.M. Soltan Dallal , L. Amani, M.Jabbari4, A. Rastegar Lari. Investigation of Resistant Bacteria in Nosocomial infections In DiedBurn Patients during Hospitalization. Infection Epidemiology & Medicine. 2013;1(1):1-7

23)Owlia P, Azimi L, Gholami A, Asghari B, Lari AR. ESBL- and MBL-mediatedresistance in Acinetobacter baumannii: a global threat to burnt patients. Infez Med. 2012Sep;20(3):182-7.

24)Mohammad Rahbar, Leila Azimi, Mona Mohammad-Zadeh, Faranak Alinejad, SomayehSoleymanzadeh, Mahboobeh Sattarzadeh, Abdolaziz Rastegar Lari. The prevalence ofnosocomial infections caused by Enterobacter cloacae and antibiotic resistant patterns insamples isolated from patients in two hospitals in Tehran. Tehran University MedicalJournal; Vol. 70, No. 3, June 2012: 183-187

CV/ARL July 2014- 6 -

25)Azimi L., Rastegar Lari A., Alaghehbandan R., Alinejad F., Mohammadpoor M. RahbarM. Kpc-Producer Gram Negative Bacteria Among Burned Infants In Motahari Hospital,Tehran: First Report From Iran. Ann. Burns Fire Disasters. 2012;7:2.74-77

26) Soltan Dallal MM., Kalafi Z., Rastegare Lari A., Hosseini SK., Rahimi foroushani A.,Deilami Khiabani Z., Nikkhahi F., Heidarzadeh S. The Impact of Environmental Factorson the Antibacterial Properties of Human Amniotic Membrane in vitro. ZUMS.2012;20:81:37-44

27)Mohammad Mehdi Soltan Dallal , Farhad Nikkhahi , Saber Molaei , Kazem Hosseini ,Zohreh Kalafi , Ahad khoshzaban , Abdolaziz Rastegar Lari , Ahmad Kheirkhah ,Mohammad Kazem Sharifi Yazdi. Effect of Amniotic Membrane Combined withCiprofloxacin in Curing the Primary Stages of Pseudomonal Keratitis. J Med Bacteriol.2012; 1 (1): pp. 31-37

28) Leila Azimi, Reza Alaghehbandan, Masoud Mohammadpoor, Abdolaziz Rastegar Lari.Identification of KPC-Producing Pseudomonas aeruginosa and Acinetobacter baumanniiin a Burned Infant: A Case Report. J Med Bacteriol. 2012; 1 ( 1 ) : pp. 46-49

29)Reza Alaghehbandan, MD, MSc, Leila Azimi, MSc, Abdolaziz Rastegar Lari, PhD.Nosocomial infections among burn patients in Tehran, Iran: a decade late. Annals ofBurns and Fire Disasters - vol. XXV - n. 1 - March 2012

30) Soltan Dalal Mohammad Mehdi, Miremadi Seyed Asghar, Sharify Yazdi MohammadKazem, Rastegar Lari Abdolaziz, Rajabi Zahra, Avadis Yans Sovan. AntimicrobialResistance Trends Of Klebsiella Spp. Isolated From Patients In Imam KhomeiniHospital. مجله دانشکده پیراپزشکی دانشگاه علوم پزشکی تهران , 2012:6:4:275-281

31)Mona Mohammad Zadeh,, Mohammad Rahbar, Mahnaz Saremi, MohammadAghazadeh, Mohammad Reza Montazer Khorasan, Mehrdad Peyrovie, Khatere SaeidiVarnamkhasti, Abdolaziz Rastegar Lari, A Study on Etiologic Agents and DrugResistance Pattern of Entropathogens Isolates from Stool Specimens of Children LessThan Five Years Old Admitted in an Iranian Hospital. Health MED. 2012:6:3:760-764

32)Mohammad Rahbar, Mona Mohammad-Zadeh, Hossein Masoumi Asl, Leila Azimi,Abdolaziz Rastegar Lari. Detection prevalence of inducible clindamycin resistance inCoagulase-Negative Staphylococci (CoNS) isolates in an Iranian 1000-bed tertiary CareHospital Using D Test. HealthMED - Volume 6 / Number 8/ 2012

CV/ARL July 2014- 7 -

33) L. Arbabi, J. Vandyoudefi, M. Bouzari, F. Rahimi, A. Rastegar Lari. AntibioticSusceptibility Pattern Among Vancomycin Resistant Enterococci Isolated From Meat andFecal Samples in Tehran Livestock Husbandries. JOURNAL OF PURE AND APPLIEDMICROBIOLOGY. Vol. 6(2),2012: 621-625

34) Leila Arbabi, Mohammad Rahbar, Mosadegh Jabbari, Mona Mohammad-Zadeh,Amirmorteza Ebrahimzadeh Namvar, Abdolaziz Rastegar Lari, Leila Azimi. Extended-spectrum β-lactamase-producing E.coli and Klebsiella pneumoniae isolated from urinarytract infections in Milad Hospital, Tehran, Iran. HealthMED - Volume 6 / Number 11 /2012

35)Abdolaziz Rastegar Lari, Faranak Alinejad, Reza Alaghehbandan, Hamid Mostafavi,Babak Asghari, Abbas Gholami. Comparison of cefuroxime and co-amoxiclav in thetreatment of acute sinusitis in a sample of the Iranian population. Le Infezioni inMedicina, n. 4, 251-255, 2012

36)Mohammad Mehdi Soltan Dallal, Ailar Sabaghi, Hedrosha Molla Agha Mirzaiee, JalilFallah Mehrabadi, Abdol Aziz Rastegar Lari, Mohammad Reza Eshraghian,Mohammad Kazem Sharifi Yazdi, Enayat Kalantar, Soven Avadisians. Prevalence ofSHV β-lactamases in Escherichia coli. African Journal of Microbiology Research Vol.6(26), pp. 5518-5522, 12 July, 2012

37)Mahshid Talebi-Taher, Maryam Latifnia, eied Ali Javad-Moosavai , Maryam Adabi,Abdolaziz Rastgar Lari, Mojtaba Fatahi Abdizadeh , Shahin Babazadeh. Risk factorsand antimicrobial susceptibility in ventilator associated pneumonia: a brief report.2012:7:9:577-589

38)Vahdani M., Azimi L., Asghari B., Bazmi F., Rastegar Lari A. PHENOTYPICSCREENING OF EXTENDED-SPECTRUM ß-LACTAMASE AND METALLO-ß-LACTAMASE IN MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSAFROM INFECTED BURNS. Ann. Burns Fire Disasters. 2012;7:78-81

39) Leila azimi , Nima Khoramabadi, Ashraf Mohabati Mobarez, Esmael Asli, NaserHarzavdi, Reza Mirnejad and Abdolaziz Rastegarlari ; Survey Of Protection OfRecombinant Cell Surface Protein 31KDa from Brucella Melitensis BALB/c Micejournal of pure and applied microbiology , march 2012;vol. 6 (1),p.69-73

CV/ARL July 2014- 8 -

40)Mommad Rahbar , mona mohammad-zadeh . hosein masoumi asl , Leila azimi andAbdolaziz Rastegar Lari: Evaluation of Five Different Phenotypic Methods ForDetection of Methicillin Resistance in Coaulase – Negative Staphylococci (CoNS)Lsolated From Cilinical Speciments journal of pure and applied microbiology , march2012;vol. 6 (1),p.85-90

41)Mohammad Mehdi Soltan Dallal phD , Farhad Nikkhahi M.Sc , Ahmad Khirkhah M.D ,Saber Molaei M.D , Seyda Kazem Hosseyni M.Sc , Abdolaziz Rastegar Lari.phD ,Abbas Rahimi Foroushani Ph.D , Ahad Khoszaban M.D , Zohre Kalafi M.Sc : The effectamniotic membarene transplantation in healing of primary stages of pseudomonaskeratitis: Tehran university medical journal ; vol .69 ,no.10 , January 2012 : 613-618

42)Hajar Mohammadi-Barzelighi, Mahshid Talebi-Taher, Maryam Adabi, Seied Ali Javad-Moosavai, Mosadegh Jabbari, Abdolaziz Rastegar Lari. Investigation of Class I, II andIII Integrons among Acinetobacter Strains Isolated from Ventilator-AssociatedPneumonia Patients in Intensive Care Unit of Rasoul Akram Hospital in Tehran, Iran. JMed Bacteriol. Autumn 2012; 1 ( 2 ) : pp. 1-9

43)Mohammadi-barzelighi H , Bakhshi B, Rastegar lari A, Pourshafie Mr ; characterizationof pathogenicity island prophage in clinical and environmental strains vibrio cholera ;Journal of medical microbiology, 2011; vol.60(12) 1742-1749

44)A.R.Lari ,F.Fallah ,A.Karimi ,G.Angoti, L.Gachkar ,Goudarzi ,A.Sanaei, Azimi L. theefficacy of multiplex PCR in comparison with Agglutination and ELISA in HumanBrucellosis Diagnostic. Iranian Journal of Clinical infectious Disease, 2011; 6:

45) Leila azimi , nima khoramabadi, ashraf mohabati mobarez,haniyeh aghababa ,amirbakhtiari , Abdolaziz Rastegarlari ; cloning,expression and purification of recombinant31 kd a cell surface protein of brucella melitensis16m ;journal of pure and appliedmicrobiology ,octobr 2011; vol.5(2),p.611-616 , 2011

46) Leila azimi , abbas motevallian , amirmorteza ebrahimzadeh namvar , babak asghari andAbdolaziz Rastgarlari ; nosocomial infections in burned patients in motaharihospital,Tehran,Iran ;dermatology research and practice :volume2011.article 436952,4pages

47) Fatemeh farahi ,nima khoramabadi, esmail asli, ashraf mohabati mobarez and abdolazizrastegarlari , immunologic evaluation of surface 18 kda protein of brucella abortus s19

CV/ARL July 2014- 9 -

cojuated with detoxified lps as antigen useful for human brucellosis vaccine in BALB/cMice Model ; journal of Animal veterinary advances 10(23):3085-3089 ,2011

48)Mohammad Mehdi Soltan Dallal phD , Mohammad azarsa msc ,Mohammad HassanShirazi phD , Abdolaziz Rastegar Lari.phD , Parviz Owlia phd , Jalil FallahMehrabadi.phD , Aylar sabaghi Msc , Hedrosha Molla Aghmirzaei, Farvaz ShamkaniMSc , Sevan Avadis Yans Msc , golnaz mobaseri Msc , Ronak BakhtiariMSc,Mohammad Kazem Sharifi Yazdi phd , Pervalance of extended spectrum beta lactamaseand CTX-M-1 producimg Escherichia coli from urine samples in Tabriz hospitals ,Zanjan university medical journal ;vol 69 ,no5 , august2011:273-278

49)Maryam Adabi ,Mosadegh Jabari, Abdolaziz RastegarLari . Distribution ofSulfamethoxazole Trimethprim Constin in Vibrio cholera isolated from Patients andenvironment in Iran;african journal of microbiology research , vol5(20),pp.3181-3185,30 september ,2011

50)Hajar Mohammadi- Barzelighi, MSC,Reza Alaghehbandan,MD, Abbas Motevallian,MD, Faranak,MD, SomayehSoleimanzadeh-Moghadam,BSC , Abdolaziz RastegarLari,Ph.D. Epidemiology of server burn injuries in a tertiary burn center inTehran,Iran;journal of Mediterranean council for burns and fire disasters – MBC ,volxxiv, no.2 ,june 2011

51)Alireza Ghafariyeh MD , Nazafarin Honarpisheh MD, Abdolaziz Rastegar Lari Ph.D.Detection of Chlamydia trachomatis in the subretinal fluid of a patient withrhegmatogenous retinal detachment:Clinical and Experimental Optomerty :(2011)vol94:2

52)Abdolaziz Rastegar Lari PhD , Mohammad Reza Pourmand PhD , Solmaz OhadianMoghadam MSc , Zahra Abdolossamadi MSc , Amirmorteza Ebrahimzadeh NamvarMSc, Babak Asghari MSc -prevalanc of pvl-containing methicillin- resistantstaphylocococcus aureus isolates among hospital staff nasal carriers : labmedicine may2011 vol 42 ,no 5,283-286

53)Alaghehbandan, R., Rastegar Lari, A., Joghataei, M.T., Islami, A., The Role of MaritalStatus, Literacy, and Urbanity in Suicida Behavior by Burns in the Province of Khorasan,Iran. Community Ment Health J. 2011;47:181-185

54)Mohammad Mehdi Soltan Dallal phD , golnaz mobaseri Msc , Jalil FallahMehrabadi.phD ,Mohammadreza eshraghiyan phd, Abdolaziz Rastegar Lari.phD ,

CV/ARL July 2014- 10 -

Hedrosha Molla Aghmirzaei, Aylar sabaghi Msc , mohammad azarsa msc ,Detection ofCTX-M-1 beta lactamase gene in Eschericha coli isolated from clinical samples bypolymererase chain reaction(pcr): Tehran university Medical Journal:vol69,no1,april2011(16-21)

55) Alaghehbandan, R., Rastegar Lari, A., Joghataei, M.T., Islami, A., Motavalian, A. Aprospective population-based study of suicidal behavior by burns in the province of Ilam,Iran. Burns (2010)jbur- 3278:no of pages6

56) Amirmorteza Ebrahim zadeh Namvar, Babak Asghari, Shoshtari Zadeh and AbdolazizRastegar Lari-.Comparison of in vitro activity of imipenim production on bacterial fromHashmi Nezhad Tehran hospitalized patients. journal of bactrialogy research nol:2 (5pp51-54) oct v2010

57)Mohammad Mehdi Soltan Dallal phD , Hedrosha Molla Aghmirzaei MS, Jalil FallahMehrabadi.phD , Abdolaziz Rastegar Lari.phD , Aylar Sabbaghi Ms , MohammadReza Eshraghian phD , Atefeh Fard Sanei Ms , Mojtaba Hanafi Abdar, : Moleculardetection TEM and AmpC (Dha, mox) broad spectrum B-lactamase in clinical isolates ifEscherichia coli :Tehran university Medical Journal: Vol. 68. No.6.Sep2010:315-320(person)

58) Salimi, H., Owlia, P., Yakhchali, B., Rastegar Lari, A. Characterization of Pseudomonasaeroginosa in Burn Patients Using PCR – Restriction Fragment Length Polymophism andRandom Amplified Polymorphic DNA Analysis . IJMS . vol 35 , no 3 , september2010

59)Abdolaziz Rastegar Lari1, Alireza Ghaffariyeh2, Noushi Etesam3, Hamid Mostafavi3,Reza Alaghehbandan4. A randomized controlled trial of 5-day regimen of azithromycinand a10-day regimen of co-amoxiclav for treatment of acute sinusitis:\ Iranian Journal ofClinical Infectious Diseases 2010;5(3):137-141

60) Salimi, H., Owlia, P., Yakhchali, B., Rastegar Lari, A. Molecular Epidemiology andDrug Susceptibility of Pseudomonas areruginosa Strains Isolated Form Burn Patients. :Iranian journal of Clinical Infection Diseas.March ,8 , 2010

61)Bahnam Haghighi , Omid Nejadi , Noushin Etesam , Hamid Mostafavi , RezaAlaghebandan , Abdolaziz Rastegar Lari :Comparison of 3-day ciprofloxacin regimenfor the treatment uncomplicated uncomplicated urinary tract infection in women : Arandomaized double – clinical trial: Iranian journal of Clinical Infection Diseas :

CV/ARL July 2014- 11 -

vol5,no2,2010

62) Salimi, H., Owlia, P., Yakhchali, B., Rastegar Lari, A. Drug Susceptibility andMolecular Epidemiology of Pseudomonas aeruginosa Isolated in a Burn Unit. Am JInfect Dis. 5(4): 301-306, 2009.

63)Razavi, Sh., Mousavizade, A, Mahmoudian, M., Rastegar Lari, A. Synergistic effects ofnoscapin and ofloxacin in fluoroquinolone resistant gram positive bactera. Med J TabrizUniversity. (Autumn 2009 Vol.31 No.3).persian

64)Rastegar Lari, A., Alaghehbandan, R., Panjeshahin, M.R., Joghataei, M.T. Suicidalbehavior by burns in the province of Fars, Iran: a socio-epidemiologic approach. Crisis30(2): 98-101, 2009.

65)Bakhshi, B., Barzelighi, H.M., Adabi, M., Rastegar Lari, A., Pourshafie, M.R. Amolecular survey on virulence associated genotypes of non-O1 non-O139 Vibrio choleraein aquatic environment of Tehran, Iran. Water Res 43(5):1441-7, 2009.

66) Shojaei Arani, A., Alaghehbandan, R., Akhlaghi, L., Shahi, M., Rastegar Lari, A.Prevalence of intestinal parasites in a population in south of Tehran, Iran. Rev Inst MedTrop Sao Paulo 50(3):145-149, 2008.

67)Rastegar Lari, A., Mohammadi, H., Masjedian F., Mahmoodian, M. Synergistic effectsof noscapin and ofloxacin in fluoroquinolone resistant enterobacteriaceae. Iranian Journalof Medicinal and Aromatic Plants. 24(1): 94-100, 2008.persian

68)Rokoei, F., Rezaei, S., Tehrani, M., Karbasian, M., Rastegar Lari, A. Comparison of theantibacterial activity of Handsept and Decosept. Iranian J Med Microb. 1(4): 53-5,2008.persian

69)Masjedian F., Valehi, F., Talebi, A., Rastegar Lari, A. Evaluation of wide broadspectrum antibiotic resistance of E. coli and Klebsiella pneumonia. Iranian J MedMicrob.1(2) : 27-34, 2007.persian

70)Rastegar Lari, A., Karimi, A, Razavi, Sh., Mostafavi, H., Farzandy, Gh. Antibioticresistance of Gram-negative rods isolated from patients in pediatric hospital in Tehran.Iranian J Med Microb. 1(1):67-9, 2007.persian

CV/ARL July 2014- 12 -

71)Rastegar Lari, A., Joghataei, M.T., Rezaei Adli, Y., Aliabadi Zadeh, Y.,Alaghehbandan, R. Epidemiology of suicide by burns in the province of Isfahan, Iran. JBurn Care Res. 28: 307-311, 2007.persian

72)Razavi, Sh., Rastegar lari, A., Ghazi, F. Molecular Subtyping of Coagulase NégativeStaphylococcus by Pulse Field Gel Electrophoresis: First Report. Med J TabrizUniversity. 28(3):53-57, 2006.persian

73)Rastegar Lari A., Alaghehbandan, R., Joghataei, M.T. Psychosocial and culturalmotivation of self-inflicted burns among Iranian women; International Psychiatry Issue 9,July 2005, 5-6.

74)Rastegar Lari, A., Alaghehbandan, R., Akhlaghi, L. Burn wound infections andantimicrobial resistance in Tehran, Iran: an increasing problem. Ann Burns Fire Disasters16(2):68-73, 2005.

75)Rastegar Lari, A., Akhlaghi, L., Falahati, M., Alaghehbandan, R. Characteristics ofdermatophytoses among children in an area south of Tehran, Iran. Mycoses 48(1):32-7,2005.

76)Noorbakhsh, S., Rastegar Lari, A., Masjedian, F., Mostafavi, H., Alaghehbandan, R.Comparison of intravenous aminoglycoside therapy with switch therapy to cefixime inurinary tract infections. Saudi Med J 25(10):1513-5, 2004.

77) Lanotte, P., Watt, S., Mereghetti, L., Dartiguelongue, N., Rastegar Lari, A., Goudeau,A., Quentin, R. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosispatients compared with those of isolates from other origins. J Med Microbiol. 2004 Jan;53(Pt 1):73-81.

78)Abdolaziz Rastegar Lari , Reza Alaghebandan: The evaluation of nosocomial infectionduring 1-year – period in the burn unit of training hospital in Istanbul ,Turkey. BURNS.29(2003)627

79)Rastegar Lari, A.,Noorbakhsh ,R. Alaghebandan,M. Habibi,S.H.Mostafavie.GH.Farzavdy :Cefixime Versus Co-Trimoxazole for Treatment of Acute Sinusitis inChildren : MONDUZZI EDITORE

80) Falahati, M., Akhlaghi, L., Rastegar Lari, A., Alaghehbandan, R. Epidemiology of

CV/ARL July 2014- 13 -

dermatophytoses in an area south of Tehran, Iran. Mycopathologia 156(4):279-287, 2003.

81)Rastegar Lari, A., Alaghehbandan, R. Epidemiological Study of Self-inflicted Burns inTehran, Iran. J Burn Care Rehabil 24(1):15-20, 2003.

82)Rastegar Lari, A., Alaghehbandan, R. Silver sulphadiazine and fundermol in the topicaltreatment of burn wounds: an experimental comparative study in rats. Arch Iranian Med5(3):170-174, 2002.persian

83)Groohi, B., Alaghehbandan, R., Rastegar Lari, A.: Analysis of 1089 burn patients inKurdistan province, Iran. Burns 2002, 28(6): 569-574.

84)Rastegar Lari, A., Panjeshahin, M-R., Talei, A-R., Rossignol, A.M., Alaghehbandan,R.: Epidemiology of childhood burn injuries in Fars province, Iran. J Burn Care Rehabil2002, 23(1): 39-45.

85)Mohajeri ,P. Rastegar Lari, A. Shahrabadi ,SH . Forohesh tehrani . in salmonella tyffeiisolated from the patient,s blood suffered from thy faid fever in Taleghani hospital ,Tehran(1996-1997). Behbood.4years – vol 1

86) Panjeshahin, M.R., Rastegar Lari, A., Talei, A.R., Shamsnia, J., Alaghehbandan, R.:Epidemiology and mortality of burns in South West of Iran. Burns 2000, 3: 219-228.

87)Alaghehbandan, R., Rossignol, A.M., Rastegar Lari, A. Paediatrics burn injury inTehran, Iran. Burns 2000, 2: 28-32.

88)Rastegar Lari, A., Alaghehbandan, R. Nosocomial infections in an Iranian burn center.Burns 2000, 26:737-740.

89)Rastegar Lari, A., Alaghehbandan, R., Nikui, R., Epidemiological study of 3341 burnspatients during three years in Tehran, Iran. Burns 2000; 26:49-53.

90)Rastegar Lari, A.Sotode ,M. Masjediyan,f. Shamshiri,A. Alinejad,F.: comparision ofofloxacin&the other antibiotics against the micro organism isolated from the patientssuffer from urinary tract infeeti. Razi, 11years ,vol l (1999)

91)Rastegar Lari, A., Alaghehbandan, R.: Experimental study of Pseudomonas aeruginosainfection in burns rats. Arch Iranian Med 1999; 2 (4), 191-194.persian

CV/ARL July 2014- 14 -

92)Rastegar lari, A., Bahrami Honar, H., Alaghehbandan, R.: Pseudomonas infections inTohid Burn Center Iran. Burns 1998, 24(7): 637-641.

93)Rastegar Lari, A., Omrani, G., Dehbashi, N., Malec, F. Evaluation of the therapeuticeffect of pefloxacin in comparison with ampicillin and gentamicin in cirrhotic patientswith spontaneous bacterial peritonities. Hepatogastroenterology 1998 May-June 45(21):783-85.

94)Rastegar Lari, A., Validi, N., Ghaffarzadeh, K., Shamshiri, A.R. In vitro activity ofcefixime versus ceftizoxime against Salmonella typhi. Pathol Biol 1997 May; 45(5): 415–9.

95)Rastegar Lari, A., Salek-Moghaddam, A.: Single-dose secnidazole versus 10-daymetronidazole therapy of giardiasis in Iranian children. J Trop Pediatric 1996 Jun; 42(3):184-5.

96)Omrani,G., Rastegar Lari, A., Khamseh, M.: Effect of single dose of Secnidazole intreatment of intestinal amoebiasis. J Pak Med Assoc 1995 Jun; 45(6): 159.

97)Rastegar Lari, A., Gold, F., Borderon, J.C., Laugier, J., Lafont, J.P.: Implantation and invivo antagonistic effects of antibiotic-susceptible Escherichia coli strains administered topremature newborns. Biol Neonate 1990; 58(2): 73-8.

98)Borderon, J.C., Rastegar Lari, A., Saliba, E., Laugier, J., Despert, F.: Effect ofceftriaxone on aerobic fecal flora in children. Pathol Biol 1990 Sep; 38(7): 716-8.

99)Rastegar Lari, A., Borderon, J.C., Gold, F., Laugier, J.: Early administration ofantibiotic susceptible strain of Escherichia coli in the intestine of the premature infant.Res Microbial 1989 Jan 140(1): 69-73.

100) Rastegar Lari, A., Borderon, J.C., Gold, F., Laugier, J.: The effect of previousantibiotherapy on the colonization of an Escherichia coli strain sensitive to antibiotics inthe digestive tract of hospitalized children. Pathol Biol 1989 Dec. 37(10): 1085-9.

101) Rastegar Lari, A., Lafont, J.P., Chaslus Dancla, E.: Use of gonotoxenic chickenfor the experimental study of in vivo plasmid transfer between human clinical strains ofE.coli. Sci Tec Anim Lab 1989, 14: 19-24.

102) Borderon, J.C., Rastegar Lari, A., Ramponi, N., Gold, F., Laugier, J.: Effect ofaztreonam on the fecal aerobic flora in children. Pathol Biol 1987 May 35 (5): 665-8

CV/ARL July 2014- 15 -

103) Borderon, J.C., Rastegar Lari, A. Laugier J., Gold, F.: The effect ofimipenem/cilastatin on the aerobic fecal flora of children. J Antimicrob Chemother 1986Dec. 18 Suppl E: 121-5.

104) Borderon, J.C., Rastegar Lari, A., Rolland, J.C., Laugier, J.: Effect of anamoxicillin-clavulanic acid combination on the aerobic fecal flora in children. Pathol Biol1985 Jun. 33 (5 pt 2): 569-72.

105) Rastegar Lari, A., Borderon, E., Barthez, J.C., Borderon, J.C.: Etude de lasensibilité aux antifongiques de souches de champignons levuriformes d’originehospitalière. Bull Soc Myco Med 1982; XI (2): 349-352.

PUBLISHED ABSTRACTS

1. Abdolaziz Rastegar Lari, Maryam Beheshti, Malihe Talebi , Abdollah Ardebili , LeilaAzimi . Detection of Tet efflux-mediated tetracycline resistance in Acinetobacterbaumannii . III International Conference on Antimicrobial Research – ICAR: 1 to 3October 2014, Madrid, spain

2. Abdolaziz Rastegar Lari, Azimi L., Morovat Taheri;alani, Rahbar M. SoleymanzadehS. Bazmi F. Comparison between phenotypic and genotypic methods for detection ofmetallo-beta-lactamases among Pseudomonas aeruginosa, isolated from burned patients.14TH INTERNATIONAL CONFERENCE ON PSEUDOMONAS LAUSANNE,SWITZERLAND, 07-11 SEPT 2013

3. Abdolaziz Rastegar Lari, Leila Azimi, Masoud Mohammadpoor. Klebsiellapneumoniae Carbapenemase Bacterial Organisms in the Infants in Burn Unit. 30th

ESPID Annual Meeting in Thessaloniki, Greece: Three Decades of ESPID; 2012

4. Abdolaziz Rastegar Lari, Reza Alaghehbandan. A Randomized Blind Study Comparing5-Day Regiment of Azithromycin with a 10-Day Regiment of Co-Amoxiclav forTreatment of Acute Bacterial Sinusitis. 52th Annual Meeting Society for PaediatricResearch, Newcastle, United Kingdom. October 14-17, 2011

3. Rastegar Lari, A., Alaghehbandan, R., Joghataei, M.T., Islami, A., Motavalian, A. Aprospective population-based study of suicidal behavior by burns in the province of Ilam,Iran. 6th European Congress on Emergency Medicine, Stockholm, Sweden, October 11-14, 2010.

4. Alaghehbandan, R., Rastegar Lari, A., Joghataei, M.T., Motavalian, A. A prospectivepopulation-based study of suicidal behavior by burns in two provinces in Iran. 9th InternationalConference on Urban Health, New York, NY, USA, October 27-29, 2010.

CV/ARL July 2014- 16 -

5. Alaghehbandan, R., Rastegar Lari, A., Joghataei, M.T., Islami, A., Motavalian, A. Aprospective population-based study of suicidal behavior by burns in the province of Ilam,Iran. 43rd Annual Society for Epidemiologic Research Meeting, Seattle, WA, USA, June23-26, 2010. Am J Epidemiol. 2010 1;171(11 Suppl):S89.

6. Rastegar Lari, A., Haghighi, B., Oskuilar, H., Nejadi, O., Etesam, N., Mostafavi, H.Comparison of three-day ciprofloxacin with seven-day ciprofloxacin treatment of urinarytract infections in women. VIIIème Congrès de la SFM – Marseille, France, June 3-5,2010. http://www.sfm.asso.fr/congres/marseille.php?ti=1&ok=0

7. Rastegar Lari, A. Haghighi, B., Etesam, N., Mostafavi, H. A randomized controlled trialof 5-day regiment of Azithromycin and a 10-day regiment of Co-Amoxiclav for treatmentof acute sinusitis. VIIIème Congrès de la SFM – Marseille, France, June 3-5, 2010.http://www.sfm.asso.fr/congres/marseille.php?ti=1&ok=0

8. Rastegar Lari, A., Alaghehbandan, R., Panjeshahin, M.R., Joghataei, M.T. Suicidalbehavior by burns in the province of Fars, Iran: a socio-epidemiologic approach. 13th

European Burns Association Congress, Lausanne, Switzerland, September 2-5, 2009.Burns 35;1(1 Suppl): S29, 2009.

9. Rastegar Lari, A., Alinejad, F., Rahmani, M., Mohamadi, H., Mostafavi, H., Farzandy,Gh., Alaghehbandan, R. Comparison of cefuroxime and amoxicillin/clavulanate in thetreatment of acute sinusitis in a sample of Iranian population. 17th European Congress ofClinical Microbiology and Infectious Diseases and 25th International Congress ofChemotherapy, Munich, Germany, 31 March - 3 April 2007, International Journal ofAntimicrobial Agents, 2007; 29 (Suppl 2):S672.http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=36966&XNSPRACHE_ID=2&XNKONGRESS_ID=49&XNMASKEN_ID=900

10. Rastegar Lari, A., Karimi, A., Habibi, M.,Razavi, SH. Antibiotic Resistance of Gram Negative Rode Isolated from Patients inPediatric Hospital in Tehran .2nd FEMS Congress of European Microbiology Madrid.Spain. July 4-8, 2006.

11. Razavi, SH., Rastegar Lari, A., Mostafavi,H., Farzandi, Gh., Habibi, M. In vitro activity of Cefepime against clinical isolates beforeintroduce to marketing in Iran. 15th Mediterranean Congress of Chemotherapy, Catania,Italy, June 2006.

12. Rastegar Lari, A., Masjedian, F., Habibi,M., Alaghehbandan, R. Extended spectrum β-lactamases in Enterobacteriaceae inTehran, Iran: a preliminary study. First Conference on New Frontiers in Microbiologyand Infection, co-organized by the European Society of Clinical Microbiology andInfectious Diseases (ESCMID) and the Federation of European Microbiological Societies(FEMS): Lessons from Escherichia coli: from basic research to clinical aspects, Villars-

CV/ARL July 2014- 17 -

sur-Ollon, Switzerland, September 4-8, 2005, Abstract Book, P 36.

13. Rastegar Lari, A., Razavi Sh. Molecular Epidemiology of Coagulase NegativeStaphylococcus Isolated from Tehran, Iran: First Report, BAGECO, Lyon, France, June2005.

14. Masgedian, F., Rastegar Lari, A., Alinejad,M., Habibi, H., Mostafavi, Gh. Comparison of Intravenous cefteriaxon and SwitchTherapy to Oral ofloxacin versus the oral ofloxacin alone in patients with UTI. 15th

European Congress of Clinical Microbiology and Infectious Diseases CopenhagenDenmark, 2-5 April, 2005.

15. Masjedian F, Bagheri KP, Habibi M,Rastegar Lari, A. Antimicrobial Susceptibilities of Staphylococcus aureus Iisolatedfrom a Hospital in Tehran. 5th Iranian Congress of Microbiology, Ahwaz, Iran, 2003.

16. Rastegar Lari A., Noorbakhsh, S.,Masjedian F, Habibi M, Alaghehbandan, R., Mostafavi, H. Comparison of IntravenousAminoglycoside Therapy with Switch Therapy to Cefixime in Urinary Tract Infections.1st FEMS Congress of European Microbiologists, Slovenia, 2003

17. Rastegar Lari, A., Noorbakhsh, S.,Alaghehbandan, R., Habibi, M., Farzandy Gh. Cefexim Versus Co-Trimoxazole forTreatment of acute sinusitis in children, 15th IFCC-FESCC European Congress ofClinical Chemistry and Laboratory Medicine, Barcelona, Spain ,2003.

18. Rastegar Lari, A., Oskouilar H, MostafaviH, Etesam N, Habibi M. Cephalosporin in Surgical Prophylaxis on Complication AfterCesarean Section the 5th International Congress on Obstetrics & Gynecology, 8-11 Dec2003, Tehran, Iran.

19. Oskouilar, H., Rrastegar Lari, A., Mostafavi, H., Etesam, N., Habibi, M. Prophylaxis WithCefteriaxon Of Infection Related Complication After Cesarean Section ,The 5thInternational Congress on Obstetrics and Gynecology Dec 8-11 2003, Tehran, Iran.

CV/ARL July 2014- 18 -

20. Rastegar Lari, A., Noorbakhsh, S., Alaghehbandan, R., Habibi, M.,Mostafavi, SH., Farzandy, GH. Cefixime versus co-trimoxazole for treatment of acutesinusitis in children. 15th IFCC - FESCC European Congress of Clinical Chemistry andLaboratory Medicine and 22nd National Congress of the Spanish Society of ClinicalBiochemistry and Molecular Pathology (SEQC), Barcelona, Spain, June 2003.

21. Rastegar Lari, A., Alaghehbandan, R. Analysis of 1089 burn patients in province ofKurdistan, Iran. Annual Meeting of American College of Epidemiology, Albuquerque,New Mexico, USA, September 2002.

22. Rastegar Lari, A., Alaghehbandan, R. Epidemiological Study of Bacterial Burn WoundInfection in Tehran, Iran. Xth International Congress of Bacteriology and AppliedMicrobiology, Paris, France, July 2002.

23. Ghadiri, B., Alaghehbandan, R, Rastegar Lari, A. Epidemiology of Intestinal Amebiasisin an Iranian Hospital. 4th European Congress of Chemotherapy and Infection & BiennialConference on Antiinfective Agents and Chemotherapy RECAI International, Paris,France, May 2002.

24. Rastegar Lari, A., Alaghehbandan, R. Epidemiology of Antimicrobial ResistancePattern and Plasmid Profile of Salmonella typhi in Iranian Patients. 21e ReunionInterdisicplinaire Chimiotherapie Anti-infectieuse, Paris, France, December 2001.

25. Alaghehbandan, R, Rastegar Lari, A. Epidemiology of Staphylococcus aureusInfections in an Iranian Burn Care Center. 2001 Congress of Epidemiology, Toronto,Canada, June 2001.

26. Rastegar Lari, A., Panjeshahin, M-R., Talei, A-R. Rossignol, A.M., Alaghehbandan, R.Epidemiology of Childhood Burn Injuries in Fars Province, Iran. 2001 Congress ofEpidemiology, Toronto, Canada, June 2001.

27. Alaghehbandan, R., Rastegar Lari, A., Panjeshahin, A.M., Talei, A.R., Epidemiology ofburn injury in childhood in Southwest of Iran. Millennium Surgical Conference, Sharjeh,UAE, Nov 2000.

28. Rastegar Lari, A., Alaghehbandan R.: Nosocomial Infections in an Iranian Burn CareCenter. 9th Congress of ECMID, Berlin, Germany, March 1999.

29. Rastegar Lari, A., Sotoudeh, M., Masjedian, F., Shamshiri, A.: Antibacterial activity ofOfloxacin against bacteria isolated from Urinary Tract Infection. 4th Congress ofUrology. Tehran, Iran, September 1999.

30. Rastegar Lari, A., Part, H., Moderns, N., Frothy, M., Jahangirikhan, A.: Efficacy andtolerability of Cefixime and amoxicillin in acute and chronic otitis media. 5eme CongressSFM, Lillie, France, April 1998.

CV/ARL July 2014- 19 -

31. Rastegar Lari, A., Vosough, S., Sotoudeh, M., Frouhi, M., Ghafarzadeh, K.H.:Antibacterial activity of Cefixime against gram-negative bacteria isolated from urinarytract infection. 5eme Congress of Société Française de Microbiologie (SFM), Lillie,France, April 1998.

32. Rastegar Lari, A., Nikui, R., Mousavi, S.M., Rahimi, R., Clinical and Para-clinicalinvestigation of the Ciprofloxacin activity in pseudomonas infection in burn patients.8eme Congress ESCMID, Lausanne, Switzerland, May 1997.

33. Rastegar Lari, A., Shakibazar, M., Gachkar, L., Shekarabi, M.: In vitro activity ofPefloxacin and Chloramphenicol against S. typhi strains isolated from patients withtyphoid fever. 4eme Congerss National de la Societe Francais de Microbiologie, Tours,France, May 1995.

34. Pourmohammadi, H., Forouhi, M., Ghaffazadeh, K.H., Rastegar Lari, A.: Investigationof laboratories effects of Cephalexine against isolated Staphylococcus aureus of patientsin Tehran hospitals. 12th Iranian Congress of Physiology and Pharmacology, Tehran, Iran,Nov 1995.

35. Ghlich-khani, P., Rastegar Lari, A., Mahmoudian, M.: Investigation of possiblemutagenic effects of various Atenolol raw materials and its degradation products in thegastric juice in vitro. 12th Iranian Congress Of Physiology and Pharmacology, Tehran,Iran, Nov 1995.

36. Esmaili-Rad, S., Daneshvar, N., Rastegar Lari, A., Mahmoudian M: Mutagenicity offood color (Herbal and synthetic) due to Ames test. 12th Iranian Congress of Physiologyand Pharmacology, Tehran, Iran, Nov 1995.

37. Tabatabai A., Rastegar Lari, A., Entezami, K.: Demonstration of fungal infectious indialysis and kidney transplantation patients in Iran. Trends in invasive fungal Infections,Manchester, UK, September 1993.

38. Kavyani M.J., Omrani C.H., Rastegar Lari, A.: The role of Fluroquinelons in treatmentof falciparum Malaria. 6th Congress European of Clinical Microbiology and InfectiousDiseases, Seville, Spain, March 1993.

39. Rastegar Lari, A., Omrani, G.H., Kavyani, Farjadian S.H.: Study of sensitivity of thegram negative bacilli and gram positive isolated from patients of ICU to new quinelones.5th International Congress of Geography Medicine, Shiraz, Iran, April 1992.

40. Rastegar Lari, A., Alborzi, A.: Quantitative assay of aerobic fecal bacteria in neonateShiraz hospital. 3eme Congress of Société Française de Microbiologie (SFM), Lyon,France, 1992.

CV/ARL July 2014- 20 -

41. Rastegar Lari, A., Behshti S.H., Moradi, M., Borderon, E.: Antimicrobial susceptibilityof Enterobacteriacea isolated from UTI to Amoxicillin and Clavulanic acid vsNorfloxacin and Cefotaxim, Shiraz, Iran. Congress of ESLMID, Norway, Oslo, 1991.

42. Rastegar Lari, A., Omrani, C.H., Deghani, F., Borderon, E.: Study of sensitivity ofisolated Pseudomonas to Azthreonem and Ceftazidim. Shiraz University 3eme congress,S.F.M. Lyon France, A3, 1992.

43. Rastegar Lari, A., Borderon J.C., Gold, F.: Rate of orally administered antibioticsensitive strain of Escherichia Coli in premature newborns within the first 6 hours of life.IX International Symposium on Gynecology, Paris, France, June 1987.

44. Rastegar Lari, A., Borderon J.C., Saliba, E., Laugier, J., Despert, F.: Effet duCeftriaxone sur la flore aérobie de l’enfant Réunion Interdisciplinaire de ChimiothérapieAnti-infectieuse, Paris, France, 1986.

45. Borderon J.C., Rastegar Lari, A., Gold, F., Laugier, J., Despert F.: Effect of 3 newLactames (Amoxicillin, Clavulanic acid, and Aztreonam) on aerobic fecal flora in infantsand children. 14th International Congress of Chemotherapy, Kyoto, Japan 1985.

46. Rastegar Lari, A.,Borderon, J.C., Rolland, J.C., Maurace C., Laugier, J.: Effet de laThienamycine sur la flore fecale aérobie de l’enfant. Réunion Interdisciplinaire deChimiothérapie Anti infectieuse, Paris, France, 1985

47. Rastegar Lari, A., Borderon, J.C., Rolland, J.C., Laugier, J.: Leffet de l’associationAmoxycilline plus Acide Clavulantique sur les germes aérobies de la flore focal. RéunionInterdisciplinaire de Chimiothérapie Anti-infectieuse, Paris, France, 1984.

AWARDS

Awarded of excellent researcher in ministry health, 11th National Award, Iran, 2010. Awarded of excellent national clinical pharmacist, Iranian Medical Council Award, Iran,

2009. Awarded of excellent national researcher in basic medical sciences, 7th Razi National

Award, Iran, 2001.

PROJECTS

Synergistic Antimicrobial Activity of Noscapine and Floroquinolone in Multi DrugResistance (MDR) Staphylococcus aueus. Credit Number MT 112, $4000

Study of Synergism Effect Noscapine with Ofloxacne in Resistance Enterobacteriaceae toFloroquinolone. Credit Number: 55MT, $1500.

CV/ARL July 2014- 21 -

Epidemiology of Suicide by Burns in the Province of Tehran, Isfahan and Shiraz, Iran..Credit Number: 849836,17/01/2005.University of Social Welfare and RehabilitationSciences, Tehran, Iran.

Epidemiology of Suicide by Burns in the Province of Ilam, Khorasan, Iran. CreditNumber: 801/4/85/11063, Oct 14, 2006. University of Social Welfare and RehabilitationSciences, Tehran, Iran.

2007-2010 2011-2012

Prevalence of nosocomial infections caused Entrobacter cloacae and determineantibiotic resistance patterns in samples isolated from patients referring to TehransMilad Hospital. 90-01-13-13407. Tehran University of Medical Sciences.

Detection of antibiotic resistance Pattern E. coli and klebsiella and identifyphenotypic lactamase enzymes (ESBL) in samples isolated from urinary tractinfections. 90-01-134-13426. Tehran University of Medical Sciences.

investigation of Acinetobacter producer extended-spectrum beta-lactamases andmetalo beta-lactamases isolated from hspitaluzed burned patients. 90-03-13-14736.Tehran University of Medical Sciences.

Survey of KPC-producing Klebsilla spp. isolated from patients in Milad and ShahidMotahari hospital, Tehran, Iran. 90-03-13-15213. Tehran University of MedicalSciences.

Detection of bla IMP , bla VIM-1 and bla VIM-2 metallo beta-lactamases gene by PCRin Acinetobacter baumannii that isolated from hospitalized burned patients. 91-01-13-16573. Tehran University of Medical Sciences.

Genetic survilance of crbapenemse enzyme in isolated Klebsielle pneumoniae fromhospitalized patients in Motahari hospital. 91-01-134-17069. Tehran University ofMedical Sciences.

Microbiological and molecular characteristics of klebsiella pneumoniae carbapenemasein carbapenem resistant pseudomonas spp. 91-01-134-17129. Tehran University ofMedical Sciences.

Investigation of Distribution and diversity of resistance gene cassette of class ١ integronsamong Campylobacter spp. Isolated from foods and patients and investigation of geneticdiversity of isolates using Pulsed-Field Gel Electrophoresis. 91-01-134-17149. TehranUniversity of Medical Sciences.

CV/ARL July 2014- 22 -

Prevalence of adeABC, tetA and tetB genes in clinical isolates of tetracycline resistantAcinetobacter baumannii. 91-01-30-16016. Tehran University of Medical Sciences.

The difference of antibiotic resistance among clinical isolates of mucoid and nonmucoidPseudomonas aeruginosa. 91-03-134-18084. Tehran University of Medical Sciences.

2013, 2014

BOOKS

1. Rastegar Lari A. et all. Pathogenic Bacteria IN Iran. Vol.1

2. Rastegar Lari, A., Alinejad, F., Alaghehbandan, R. Guide to Antimicrobial Therapy.Keyhan Ghraph, Publisher, Tehran, First Edition, 1999. (In Farsi)

3. Rastegar Lari A., Hoseinpour P.and Ghaderi B.,Antibio Garde, ISBN 964-7998-08-2,2003, Tehran, Iran.

4. Alaghehbandan, R., Rastegar Lari, A. Examples from Burn Units in Iran, ClinicalEpidemiology (Box 3.1): In Principle and Practice of Epidemiology: An EngagedApproach. Rossignol, A.M. First Edition (2004). New York, NY, McGraw-HillCompanies, Inc., ISBN 978-0-07-286939-2.

CV/ARL July 2014- 23 -